Mechanism of Anti-Human Immunodeficiency Virus Activity of -D-6-Cyclopropylamino-2',3'-Didehydro-2',3'-Dideoxyguanosine (original) (raw)
Mechanism of Anti-Human Immunodeficiency Virus Activity of β- d -6-Cyclopropylamino-2′,3′-Didehydro-2′,3′-Dideoxyguanosine
Selwyn Hurwitz
Antimicrobial Agents and Chemotherapy, 2005
View PDFchevron_right
Novel Use of a Guanosine Prodrug Approach To Convert 2',3'-Didehydro-2',3'-Dideoxyguanosine into a Viable Antiviral Agent
Chung Chu
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus
Thomas Spector
Journal of Medicinal Chemistry, 1993
View PDFchevron_right
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus
HIDEKI NAKASHIMA
Antimicrobial Agents and Chemotherapy, 1987
View PDFchevron_right
Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides
Devron Averett
Antimicrobial Agents and Chemotherapy, 1994
View PDFchevron_right
Synthesis, Antiviral Activity, and Mechanism of Drug Resistance of d- and l-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluorocarbocyclic Nucleosides
Jianing Wang
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
Devron Averett
Antimicrobial agents and chemotherapy, 1997
View PDFchevron_right
Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T)
Ana San Felix
The Journal of biological chemistry, 1992
View PDFchevron_right
4'Ethynyl Nucleoside Analogs: Potent Inhibitors of Multidrug-Resistant Human Immunodeficiency Virus Variants In Vitro
Hiroyuki Gatanaga
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
D-and L-2', 3'-didehydro-2', 3'-dideoxy-3'-fluoro-carbocyclic nucleosides: Synthesis, anti-HIV activity and mechanism of resistance
Chung Chu
Journal of medicinal …, 2007
View PDFchevron_right
Synthesis and anti-HIV evaluation of 2',3'-dideoxyribo-5-chloropyrimidine analogs: reduced toxicity of 5-chlorinated 2',3'-dideoxynucleosides
Koen Augustyns, Arthur Van Aerschot
Journal of Medicinal Chemistry, 1990
View PDFchevron_right
l-2‘,3‘-Didehydro-2‘,3‘-dideoxy-3‘-fluoronucleosides: Synthesis, Anti-HIV Activity, Chemical and Enzymatic Stability, and Mechanism of Resistance
Giuseppe Gumina
Journal of Medicinal Chemistry, 2003
View PDFchevron_right
Asymmetric Synthesis and Antiviral Activities of l-Carbocyclic 2‘,3‘-Didehydro-2‘,3‘-dideoxy and 2‘,3‘-Dideoxy Nucleosides
Chung Chu
Journal of Medicinal Chemistry, 1999
View PDFchevron_right
Inhibition of HIV-1 by Octadecyloxyethyl Esters of (S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl] Nucleosides and Evaluation of Their Mechanism of Action
Karl Y Hostetler
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
Comparative activity of 2′,3′-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells
Bogdan Doboszewski
Biochemical Pharmacology, 1988
View PDFchevron_right
Metabolism of 2 Ј ,3 Ј -Dideoxy-2 Ј ,3 Ј -Didehydro-  - L ( Ϫ )-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus  - D ( ϩ ) Nucleoside Analogs In Vitro
Marina Kukhanova
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Antiviral activity and intracellular metabolism of Bis (tButyISATE) phosphotriester of beta-L-2', 3' dideoxyadenosine, a potent inhibitor of HIV and HBV replication
David Egron
Antiviral chemistry & …, 2001
View PDFchevron_right
Inhibition of Human Immunodeficiency Virus by a New Class of Pyridine Oxide Derivatives
Ramon Eritja
Antimicrobial Agents and Chemotherapy, 2003
View PDFchevron_right
Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2′-β-fluoro-2′,3′-dideoxyadenosine in peripheral blood mononuclear cells
John Driscoll
Biochemical Pharmacology, 1995
View PDFchevron_right
Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2′,3′-Dideoxy-3′-C-(hydroxymethyl)-β-?-erythropentofuranosyl] cytosine
Joseph Colacino
Bioorganic & Medicinal Chemistry, 1998
View PDFchevron_right
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnuc...
Mj Perez
Proceedings of the National Academy of Sciences, 1993
View PDFchevron_right
1,3-Dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes
Chung Chu
Journal of Medicinal Chemistry, 1993
View PDFchevron_right
Synthesis of novel 3′,4′-seco analogues of didehydro dideoxy nucleosides as potential antiviral agents
M. Jokic
Tetrahedron Letters, 1994
View PDFchevron_right
5-Modified-2′-dU and 2′-dC as Mutagenic Anti HIV-1 Proliferation Agents: Synthesis and Activity
Roland Marquet, Jean-christophe Paillart, Alain Burger
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Novel Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1)
palayakotai R raghavan
Journal of Medicinal Chemistry
View PDFchevron_right
Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity
Chung Chu
Journal of Medicinal Chemistry, 1992
View PDFchevron_right
Study of the Effects on DNA of Two Novel Nucleoside Derivatives Synthesized as Potential Anti-HIV Agents
Ahmed O Maslat
Drug and Chemical Toxicology, 2007
View PDFchevron_right
In Search of New Inhibitors of HIV-1 Replication: Synthesis and Study of 1-(2′-Deoxy-β-D-Ribofuranosyl)-1,2,4-Triazole-3-Carboxamide as a Selective Viral Mutagenic Agent
Roland Marquet, Jean-christophe Paillart
Nucleosides, Nucleotides and Nucleic Acids, 2007
View PDFchevron_right
A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics
Reza Sadaie
Antiviral Research, 2004
View PDFchevron_right
Adenine and Deazaadenine Nucleoside and Deoxynucleoside Analogues: Inhibition of Viral Replication of Sheep MVV (In Vitro Model for HIV) and Bovine BHV-1
Gloria Cristalli, Catia Lambertucci
Bioorganic & Medicinal Chemistry, 2002
View PDFchevron_right
Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses
Selwyn Hurwitz
Antiviral Research, 2006
View PDFchevron_right
Relationship between Antiviral Activity and Host Toxicity: Comparison of the Incorporation Efficiencies of 2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine-Triphosphate Analogs by Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Human Mitochondrial DNA Polymerase
Kenneth Johnson
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Structure−Activity Relationships of 2‘-Fluoro-2‘,3‘-unsaturated d-Nucleosides as Anti-HIV-1 Agents
Giuseppe Gumina
Journal of Medicinal Chemistry, 2002
View PDFchevron_right
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis
R. Pauwels
Journal of Medicinal Chemistry, 1987
View PDFchevron_right
Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants
Manfred Rösner
Proceedings of the National Academy of Sciences of the United States of America, 1996
View PDFchevron_right